Early Aggressive Versus Initially Conservative Therapy in Elderly Patients With Non-ST-Elevation Acute Coronary Syndrome
Primary Purpose
Acute Coronary Syndrome
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
systematic coronary intervention
coronary intervention only for cases refractory to medical therapy
Sponsored by

About this trial
This is an interventional treatment trial for Acute Coronary Syndrome focused on measuring coronary artery disease, coronary angioplasty, coronary artery bypass surgery, elderly
Eligibility Criteria
Inclusion Criteria:
- Over 74 years of age.
- Have had symptoms suggestive of acute myocardial ischemia at rest within 48 hours prior to randomization, and ischemic ECG changes or elevated levels of biochemical markers of myocardial damage.
- Provide written informed consent before randomization.
Exclusion Criteria:
- Secondary causes of acute myocardial ischemia.
- Ongoing myocardial ischemia despite maximally titrated anti-ischemic therapy (invasive strategy recommended).
- Ongoing signs of acute heart failure despite treatment (invasive strategy recommended).
- Percutaneous coronary intervention or bypass surgery within 30 days prior to randomization.
- A serum creatinine level greater than 2.5 mg/dL.
- Active internal bleeding, history of hemorrhagic diathesis or recent transfusion of red blood cells, whole blood or platelets.
- History of cerebrovascular accident within the previous month.
- Known current platelet count < 90,000 cells/mL.
- Gastrointestinal or genitourinary bleeding of clinical significance within 6 weeks prior to randomization.
- Concomitant severe obstructive lung disease, malignancy or neurologic deficit limiting follow-up or adherence to the study protocol.
- Participation in any phase of another clinical research study involving the evaluation of another investigational drug or device within 30 days prior to randomization.
- Inability to give at least verbal informed consent to the study.
Sites / Locations
- Dept. of Cardiology "A. De Gasperis"
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
1
2
Arm Description
Coronary angiography within 72h and revascularization as clinical indicated
Initially conservative treatment with coronary angiography only for recurrent ischemia
Outcomes
Primary Outcome Measures
The composite of all-cause mortality, myocardial (re)infarction, disabling stroke and re-hospitalization for cardiovascular causes or severe bleeding within 1 yr.
Secondary Outcome Measures
CV mortality at 1 yr; All-causes mortality, myocardial re/infarction 1 yr; Composite of death, myocardial re/infarction, disabling stroke, rehospitalization due to cardiovascular or clinically bleeding causes at 1 yr; Major bleeding, stroke at 1 yr
Full Information
NCT ID
NCT00510185
First Posted
July 31, 2007
Last Updated
March 13, 2019
Sponsor
Niguarda Hospital
Collaborators
Italian Society of Cardiology
1. Study Identification
Unique Protocol Identification Number
NCT00510185
Brief Title
Early Aggressive Versus Initially Conservative Therapy in Elderly Patients With Non-ST-Elevation Acute Coronary Syndrome
Official Title
Italian Elderly ACS Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
October 2007 (undefined)
Primary Completion Date
June 2010 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Niguarda Hospital
Collaborators
Italian Society of Cardiology
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A randomized study comparing an early aggressive with an initially conservative strategy in patients >74 y.o. with non-ST-elevation acute coronary syndrome.
This study had generated a secondary one:
"Causes of death in elderly patients with Non-ST-Elevation Acute Coronary Syndrome; predictors of in-hospital and follow-up death"
Detailed Description
Patients >74 y.o. with non-ST-elevation acute coronary syndrome will be randomised to an early aggressive (coronary angiography within 72 hours followed, when indicated, by revascularization) or an initially conservative strategy (medical therapy, and coronary angiography only for refractory ischemia).
As reported in Amendment 1, the trial was stopped in May 2010 after the enrolment of 313 patients, which was the minimum sample size calculated in order to achieve a 80% power of detecting a difference in the primary-endpoint rate from 40% in the conservative arm to 25% in the invasive arm, based upon the log-rank test for survival curves (1-beta 0.80; 2-tailed alpha 0.05)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Coronary Syndrome
Keywords
coronary artery disease, coronary angioplasty, coronary artery bypass surgery, elderly
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
313 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Coronary angiography within 72h and revascularization as clinical indicated
Arm Title
2
Arm Type
Sham Comparator
Arm Description
Initially conservative treatment with coronary angiography only for recurrent ischemia
Intervention Type
Other
Intervention Name(s)
systematic coronary intervention
Intervention Description
Coronary angiography within 72 hrs
Intervention Type
Other
Intervention Name(s)
coronary intervention only for cases refractory to medical therapy
Intervention Description
Initially conservative treatment with coronary angiography only for recurrent ischemia
Primary Outcome Measure Information:
Title
The composite of all-cause mortality, myocardial (re)infarction, disabling stroke and re-hospitalization for cardiovascular causes or severe bleeding within 1 yr.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
CV mortality at 1 yr; All-causes mortality, myocardial re/infarction 1 yr; Composite of death, myocardial re/infarction, disabling stroke, rehospitalization due to cardiovascular or clinically bleeding causes at 1 yr; Major bleeding, stroke at 1 yr
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Over 74 years of age.
Have had symptoms suggestive of acute myocardial ischemia at rest within 48 hours prior to randomization, and ischemic ECG changes or elevated levels of biochemical markers of myocardial damage.
Provide written informed consent before randomization.
Exclusion Criteria:
Secondary causes of acute myocardial ischemia.
Ongoing myocardial ischemia despite maximally titrated anti-ischemic therapy (invasive strategy recommended).
Ongoing signs of acute heart failure despite treatment (invasive strategy recommended).
Percutaneous coronary intervention or bypass surgery within 30 days prior to randomization.
A serum creatinine level greater than 2.5 mg/dL.
Active internal bleeding, history of hemorrhagic diathesis or recent transfusion of red blood cells, whole blood or platelets.
History of cerebrovascular accident within the previous month.
Known current platelet count < 90,000 cells/mL.
Gastrointestinal or genitourinary bleeding of clinical significance within 6 weeks prior to randomization.
Concomitant severe obstructive lung disease, malignancy or neurologic deficit limiting follow-up or adherence to the study protocol.
Participation in any phase of another clinical research study involving the evaluation of another investigational drug or device within 30 days prior to randomization.
Inability to give at least verbal informed consent to the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefano Savonitto, MD
Organizational Affiliation
Azienda Ospedaliera Ospedale Niguarda Ca' Granda-Dept. of Cardiology "A. De Gasperis"
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Stefano De Servi, MD
Organizational Affiliation
Dept. of Cardiology - Ospedale Civile di Legnano - Italy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept. of Cardiology "A. De Gasperis"
City
Milan
ZIP/Postal Code
20162
Country
Italy
12. IPD Sharing Statement
Citations:
PubMed Identifier
18301136
Citation
Savonitto S, De Servi S, Petronio AS, Bolognese L, Cavallini C, Greco C, Indolfi C, Visconti LO, Piscione F, Ambrosio G, Galvani M, Marzocchi A, Santilli I, Steffenino G, Maseri A. Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study. J Cardiovasc Med (Hagerstown). 2008 Mar;9(3):217-26. doi: 10.2459/JCM.0b013e3282f7c8df.
Results Reference
background
PubMed Identifier
25593211
Citation
Toso A, Servi SD, Leoncini M, Morici N, Murena E, Antonicelli R, Cavallini C, Petronio AS, Steffenino G, Piscione F, Bellandi F, Savonitto S. Acute Kidney Injury in Elderly Patients With Non-ST Elevation Acute Coronary Syndrome: Insights From the Italian Elderly: ACS Study. Angiology. 2015 Oct;66(9):826-30. doi: 10.1177/0003319714567738. Epub 2015 Jan 15.
Results Reference
derived
PubMed Identifier
24917216
Citation
Savonitto S, Morici N, Cavallini C, Antonicelli R, Petronio AS, Murena E, Olivari Z, Steffenino G, Bonechi F, Mafrici A, Toso A, Piscione F, Bolognese L, De Servi S. One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia. J Am Geriatr Soc. 2014 Jul;62(7):1297-303. doi: 10.1111/jgs.12900. Epub 2014 Jun 10.
Results Reference
derived
PubMed Identifier
22995877
Citation
Savonitto S, Cavallini C, Petronio AS, Murena E, Antonicelli R, Sacco A, Steffenino G, Bonechi F, Mossuti E, Manari A, Tolaro S, Toso A, Daniotti A, Piscione F, Morici N, Cesana BM, Jori MC, De Servi S; Italian Elderly ACS Trial Investigators. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. JACC Cardiovasc Interv. 2012 Sep;5(9):906-16. doi: 10.1016/j.jcin.2012.06.008.
Results Reference
derived
Learn more about this trial
Early Aggressive Versus Initially Conservative Therapy in Elderly Patients With Non-ST-Elevation Acute Coronary Syndrome
We'll reach out to this number within 24 hrs